Voie intranasale And NotChristine Wohlford-Lenane

List of bibliographic references

Number of relevant bibliographic references: 3.

Ident.	Authors (with country if any)	Title
000079	Yohichi Kumaki [États-Unis] ; Jane Ennis [Canada] ; Ramtin Rahbar [Canada] ; Jeffrey D. Turner [Canada] ; Miles K. Wandersee [États-Unis] ; Aaron J. Smith [États-Unis] ; Kevin W. Bailey [États-Unis] ; Zachary G. Vest [États-Unis] ; Jason R. Madsen [États-Unis] ; Joseph K.-K. L [États-Unis] ; Dale L. Barnard [États-Unis]	Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model
000367	Mary C. Hu [États-Unis] ; Taff Jones [Canada] ; Richard T. Kenney [États-Unis] ; Dale L. Barnard [États-Unis] ; David S. Burt [Canada] ; George H. Lowell [Canada]	Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice
000618	DI QU [République populaire de Chine] ; BOJIAN ZHENG [Hong Kong] ; XIN YAO [République populaire de Chine] ; YI GUAN [Hong Kong] ; Zheng-Hong Yuan [République populaire de Chine] ; Nan-Shan Zhong [République populaire de Chine] ; Li-Wei Lu [Hong Kong] ; Jian-Ping Xie [République populaire de Chine] ; Yu-Mei Wen [République populaire de Chine]	Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021